Interventional Cardiology, 2010 (vol. 9), issue 4

Editorial

Transkatetrální implantace aortální chlopně: zaměřeno na transapikální přístup

Jan Vojáček, Jan Harrer

Interv Akut Kardiol. 2010;9(4):171-174  

Original articles

Cardiospecific markers during acute myocardial infarction - protein biochip utilization

Lucie Horáková, Radek Pudil, Miloš Tichý, Martina Ulrychová, Jan Vojáček

Interv Akut Kardiol. 2010;9(4):175-179  

The aim of the study was the monitoring of plasma levels of isoenzyme of creatine kinase (CKMB mass), myoglobin (MYO), BB isoenzyme of glycogen phosphorylase (GPBB), heart-type fatty acid binding protein (H-FABP), carbonic anhydrase III (CA III), and cardiac troponin I (cTnI) in patients with acute myocardial infarction during 5 days as well as screening of the sensitivity of the new technology of the protein biochip microarray that was used to assess plasma levels of these markers (System Evidence Investigator™, Randox Laboratories Ltd., Great Britain). The plasma level of H-FABP was markedly elevated in major part of patients in the...

Minimally invasive thoracoscopic ablation for atrial fibrillation

Marek Pojar, Jan Vojáček, Luděk Haman, Petr Pařízek

Interv Akut Kardiol. 2010;9(4):180-184  

Objective: We report our experiences with new technique of minimally invasive surgical ablation of lone atrial fibrillation. Methods: There were 8 patients at mean age of 57 ± 11 years who underwent bilateral totally thoracoscopic ablation of symptomatic paroxysmal AF (6 patients; 75 %) or persistent AF (2 patients; 25 %). Box-lesion ablation procedure included bilateral pulmonary vein ablation together with the posterior wall of the left atrium using irrigated bipolar radiofrequency with the documentation of conduction block. Stapling closure of the left atrial appendage was performed in one patient. Results: There was no intra- or...

Review articles

Mild therapeutic hypothermia significantly improves the results of the cardiopulmonary resuscitation

Bronislav Klementa, Olga Klementová, Milan Adamus, Radovan Uvízl, Pavel Folwarczny

Interv Akut Kardiol. 2010;9(4):186-189  

In spite of the fact that the effect of therapeutic hypothermia on human beeings is known for many centuries, it is still studied intensively. The studies watch the therapeutic hypothermia influence not only on surviving after the ischemic stroke, but also on the final neurological condition of the patients afflicted. There are emerging new modern extra- and intravascular techniques which improves not only the speed of start, temperature swings, but mainly the treatment results. Mild therapeutic hypotermia (MTH) after a successful resuscitation has already become a treatment standard in hospitals with regard to improving neuro logical conditions...

Markers of myocardial ischemia: the blind alley or the future of laboratory diagnostics in cardiology ?

Jaroslav Dušek, James Lago Chek, Josef Šťásek, Josef Bis, Martina Vašatová, Jan Vojáček

Interv Akut Kardiol. 2010;9(4):190-194  

The article provides the current data on markers of myocardial ischemia – ischemia modified albumin, unbound free fatty acids and alludes also to cholin and glycogenphosphorylase B – markers on the border between myocardial ischemia and necrosis. Advantages and disadvantages of ischemia modified albumin are analysed with regards to the absence of sufficient number of evidence based data about this marker. This is the main reason, which inhibits its clinical use. We have also very poor information about unbound free fatty acids and their laboratory analysis is very complicated.

Biodegradable coronary stents

Martin Mates

Interv Akut Kardiol. 2010;9(4):195-197  

Biodegradable coronary stents are manufactured from a material, which is completely absorbed in months to years after implantation. In theory there are several advantages related to biodegradable stents, although clinical experience is very limited at the moment. This article gives a review of used technologies, results of clinical trials and explain possible advantages of bioabsorbable stents.

Case reports

The use of automated external cardiac massage during primary PCI

Petr Kala, Radim Karlík, Otakar Boček, Petr Neugebauer, Martin Poloczek, Jiří Pařenica, Miroslav Vytiska, Irena Kolářová, Květoslava Hladilová, Ludmila Dostálová, Petr Jeřábek

Interv Akut Kardiol. 2010;9(4):204-207  

Cardiopulmonary resuscitation especially in patients with acute myocardial infarction is a common part of the cathlab work. Really problematic can be the need for cardiac massage during the procedure requiring interruption of the cathetrisation and beginning of the external cardiac massage manually. In this case we report the use of relatively new and highly effective technique – automated external cardiac massage LUCAS (Lund University Cardiac Arrest System). Despite some technical limitations it is possible to continue with the procedure during the massage.

Aggressive approach to thrombolytic therapy of massive pulmonary embolism

Viktor Talafa, Dalibor Pastucha

Interv Akut Kardiol. 2010;9(4):208-210  

Pulmonary embolism is a relatively common condition, particularly among elderly and high-risk patients. The annual incidence ranges from 0.8 to 2 cases in 1,000 patients. It is frequently caused by a sudden obstruction of pulmonary vasculature with thrombembolus originating from the deep venous system of lower extremities. Deep vein thrombosis and pulmonary embolism are both part of a single process – venous thromboembolic disease. Our case report describes a rare case of repeated thrombolytic treatment in a patient with two episodes of cardiogenic shock on the basis of recurrent massive pulmonary embolism within a short interval of 25 hours.

Video case reports

A view of septal occluders in three-dimensional transesophageal echocardiography in real time

Martin Mates, Tomáš Mráz, Petr Kmoníček, Eva Mandysová, Petr Neužil

Interv Akut Kardiol. 2010;9(4):212-214  

Case reports of two patients undergoing catheter intervention of the atrial septum (a closure foramen ovale and atrial septum defect) demonstrate separate imaging modalities emphasising the role of the transesophageal echocardiography.

Pharmacotherapy

Hypertensive crisis, emergent and urgent hypertensive situations -

Tomáš Janota, Jiří Widimský

Interv Akut Kardiol. 2010;9(4):198-202  

current state of knowledge and guidelines for the management Hypertensive crisis is an acute, life-threatening condition associated with a substantial sudden increase in blood pressure. If the increase of blood pressure is accompanied by an acute damage of brain, cardiovascular system, eye ground or kidneys, it is referred to as an emergent hypertensive situation. In case of complaints comprising chest pain, shortness of breath, headache, epistaxis, weakness, faintness or seizure alone without organ damage, it is referred to as an urgent hypertensive situation. Treatment of emergent situations is conducted under a permanent monitoring in...

Information

Arytmologové na XVIII. výročním sjezdu České kardiologické společnosti

Miloš Táborský

Interv Akut Kardiol. 2010;9(4):216  

Intervenční kardiologie na XVIII. výročním sjezdu České kardiologické společnosti

Jaroslav Dušek

Interv Akut Kardiol. 2010;9(4):217  

Akutní kardiologie na XVIII. výročním sjezdu ČKS v Brně 2010

Tomáš Janota

Interv Akut Kardiol. 2010;9(4):218-219  

Evropský kongres perkutánních koronárních revaskularizací - EuroPCR 2010

Petr Kala

Interv Akut Kardiol. 2010;9(4):221-222  


Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.